UNIMARK REMEDIES LTD (India) holds 39 active US FDA Type II Drug Master Files and 13 inactive, has DMF or CEP filings on record for 34 active ingredients and is linked to 2 FDA-registered manufacturing sites. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “UNIMARK REMEDIES LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/unimark-remedies-ltd

Overview

UNIMARK REMEDIES LTD is an active pharmaceutical ingredient (API) supplier with 39 active FDA Type II Drug Master Files, covering 7-AMINO-3-CHLORO-3-CEPHEM-4-CARBOXYLIC ACID (7ACCA); ALBENDAZOLE USP; ARMODAFINIL; BENAZEPRIL HYDROCHLORIDE USP; BUSPIRONE HYDROCHLORIDE USP; CEFIXIME USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which UNIMARK REMEDIES LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

UNIMARK REMEDIES LTD holds 39 active (52 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • STERILE MIXTURE FOR MEROPENEM AND SODIUM CARBONATE (DRUG PRODUCT INTERMEDIATE)Active2014-06-19
  • STERILE MIXTURE FOR IMIPENEM, CILASTATIN SODIUM AND SODIUM BICARBONATE (DRUG PRODUCT INTERMEDIATE)Active2014-06-18
  • IMIPENEM USP (STERILE)Active2014-06-16
  • CILASTATIN SODIUM USP (STERILE)Active2014-06-12
  • MEROPENEM USP (STERILE)Active2014-06-07
  • CILASTATIN ACID (INTERMEDIATE)Active2014-06-03
  • DORIPENEM STERILEActive2014-05-30
  • IMIPENEM CRUDE (INTERMEDIATE)Active2014-05-23
  • DORIPENEM CRUDE (INTERMEDIATE)Active2014-04-25
  • NITROFURANTOIN ANHYDROUS USP (MACROCRYSTALS)Active2012-06-28
  • CEFIXIME USPActive2012-06-08
  • MEROPENEM TECHNICALActive2012-03-31
  • FEBUXOSTATEActive2012-02-24
  • DRONEDARONE HYDROCHLORIDEActive2012-02-16
  • BUSPIRONE HYDROCHLORIDE USPActive2011-11-16
  • MOXIFLOXACIN HYDROCHLORIDE USPActive2011-10-25
  • ARMODAFINILActive2011-06-01
  • MONTELUKAST SODIUM (PROCESS B)Active2010-11-02
  • RIZATRIPTAN BENZOATEActive2010-09-27
  • SOLIFENACIN SUCCINATEActive2010-07-28
  • NITROFURANTOIN ANHYDROUS CRYSTALS USPActive2010-03-12
  • PALIPERIDONEActive2010-02-20
  • NITROFURANTOIN ANHYDROUS USPActive2010-02-16
  • NITROFURANTOIN MONOHYDRATE USPActive2010-02-16
  • TOPIRAMATE USP (PROCESS A)Active2009-11-30
  • LANTHANUM CARBONATE OCTAHYDRATEActive2009-11-05
  • FLECAINIDE ACETATE USP (PROCESS B)Active2009-10-14
  • LAMOTRIGINE USPActive2009-05-25
  • PIMOZIDE USP [TYPE-2]Active2009-04-23
  • TIGECYCLINE TECHNICALActive2008-11-29
  • TOPIRAMATE USPActive2007-10-05
  • CEFUROXIME AXETIL USPActive2007-05-23
  • 7-AMINO-3-CHLORO-3-CEPHEM-4-CARBOXYLIC ACID (7ACCA)Active2007-01-09
  • RAMIPRIL USPActive2006-06-15
  • BENAZEPRIL HYDROCHLORIDE USPActive2006-05-31
  • FLECAINIDE ACETATE USPActive2006-03-23
  • MELOXICAM USPActive2005-04-19
  • ALBENDAZOLE USPActive2004-11-08
  • LISINOPRIL USPActive2004-08-26
  • MONTELUKAST SODIUM USP (PROCESS-C)Inactive2012-11-06
  • DARIFENACIN HYDROBROMIDEInactive2012-09-27
  • TENOFOVIR DISOPROXIL FUMARATEInactive2012-08-29
  • MONTELUKAST SODIUM (PROCESS A)Inactive2010-06-02
  • CANDESARTAN CILEXETILInactive2010-05-12
  • PROPOFOL USPInactive2010-04-29
  • OLMESARTAN MEDOXOMILInactive2010-03-20
  • HYDROXYCHLOROQUINE SULFATE USPInactive2010-03-12
  • ESZOPICLONEInactive2010-02-20
  • MONTELUKAST SODIUM (NI)Inactive2008-08-14
  • CEFPROZIL USPInactive2008-03-15

Showing the 50 most relevant of 52 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to UNIMARK REMEDIES LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

3 FDA enforcement records linked to this company.

  • warning_letter2016-08-12

    FDA Warning Letter (drug product)

  • warning_letter2016-08-12

    FDA Warning Letter (drug product)

  • warning_letter2015-09-29

    FDA Warning Letter (drug product)

For suppliers

Is this UNIMARK REMEDIES LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.